Skip to main content
. 2024 Oct 29;13:e56882. doi: 10.2196/56882

Table 1.

Data collection and time points.

Measures Instrument Recruitment screener Baseline 3 months post baseline 6 months post baseline 12 months post partum
Primary and Secondary Outcomesa

Depressive symptoms Patient Health Questionnaire-8 (PHQ-8) [40] X
X X

Moderate/vigorous intensity physical activity ActiGraph GT3X+ (7 days); Pregnancy Physical Activity Questionnaire (PPAQ) [41]
X X X
Additional Outcomes

Perceived stress Perceived Stress Scale (PSS-10) [42]
X X X

Anxiety symptoms Generalized Anxiety Disorder (GAD-7) [43]
X X X

Sleep quality and duration Pittsburg Sleep Quality Index (PSQI) [44]
X X X

Mother and infant bonding Mother-to-Infant Bonding Scale (MIBS) [45]
X X


Infant development at 12 months Ages and Stages Questionnaire (ASQ-3) [46]



X

Participant satisfaction


X

Potential Mediators for Physical Activity (PA)

Self-efficacy

Modified self-efficacy to overcome barriers to PA Scale [47]
X X


Perceived barriers Modified barriers to being physically active scale [47]
X X

Potential Effect Modifiers

Physical activity before pregnancy Stanford Leisure-Time Activity Categorical Item (L-Cat) [48], modified to reflect year before pregnancy
X



Physical activity during pregnancy Stanford L-Cat, modified to reflect pregnancy
X


Covariates and Confounders

Demographic characteristics (survey-based: number of children and ages, race/ethnicity, education, income, employment, marital status; electronic health record–based: maternal age) N/Ab
X



Baseline infant development Mobility and behavior questions
X



Social support for PA Modified family or friend support for participation in exercise scale [47,49]
X



COVID-19 stress and coping mechanisms N/A
X



Health behaviors (smoking, alcohol, breastfeeding) N/A
X X X
Adverse Event Reporting

Injuries or illness related to exercise N/A

X X

aPrimary outcomes were depressive symptoms and device-based physical activity (PA) measured at the 3-month follow-up. Secondary outcomes were depressive symptoms and device-based PA at the 6-month follow-up and self-reported PA at the 3- and 6-month follow-ups.

bNot applicable.